Search Protocols under revision. Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupGastroenterologic OncologyRegional therapyDiseaseColon CancerSubgroupICD10C18.0C18.2C18.3C18.4C18.5C18.6C18.7C18.8C19MeSHColonic NeoplasmsColorectal NeoplasmsSequenceAntineoplastic therapySubstanceDrug-Eluting BeadsIodixanolIrinotecanSubstanceDrug-Eluting BeadsIodixanolIrinotecanSubstanceDrug-Eluting BeadsIodixanolIrinotecanSubstanceDrug-Eluting BeadsIodixanolIrinotecanAnzahl Substanzen3 RadiotherapySupportive therapySubstanceBalanced Crystalloid SolutionDexamethasoneGranisetronSubstanceBalanced Crystalloid SolutionDexamethasoneGranisetronSubstanceBalanced Crystalloid SolutionDexamethasoneGranisetronSubstanceBalanced Crystalloid SolutionDexamethasoneGranisetronAnzahl Substanzen3Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentionpalliativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorArnold DDiseaseKolorektales Karzinom mit Lebermetastasen, ECOG 0-3OriginAsklepios Tumor Centre Hamburg, AK Altona, Hamburg; CIREL studyProtocols in Revision 1 protocol foundDEB-TACE - Irinotecan 100, Colorectal Carcinoma (PID2877 V1.0)
